Takefuji Seiko, Murase Takashi, Sugimura Yoshihisa, Takagishi Yoshiko, Hayasaka Shizu, Oiso Yutaka, Murata Yoshiharu
Department of Genetics, Research Institute of Environmental Medicine, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan.
Exp Neurol. 2007 Mar;204(1):88-94. doi: 10.1016/j.expneurol.2006.09.025. Epub 2006 Nov 28.
Osmotic demyelination is a serious disease caused by rapid correction of hyponatremia. In humans, demyelinative lesions occur preferentially in the central pons, and thus are termed central pontine myelinolysis. Although accumulation of microglia has been reported in such demyelinative lesions, their role in the pathogenesis of osmotic demyelination remains unclear. We examined the expression of cytokines in microglia that accumulated in the demyelinative lesions in a rat model of osmotic demyelination. Hyponatremia was induced in rats by a combination of dDAVP infusion and liquid diet feeding. After 7 days, serum sodium levels were rapidly corrected by hypertonic saline injection. The rats developed severe motor deficits, and marked demyelinative lesions were found in the midbrain and cerebral cortex. In the area of the demyelinative lesions, massive accumulations of microglia were observed that expressed the proinflammatory cytokines TNF-alpha and IFN-gamma as well as iNOS. In contrast, in hyponatremia corrected rats treated with lovastatin, which is known to inhibit microglial infiltration in various animal models of CNS disease, neurological impairments and the degree of demyelination were significantly ameliorated. Lovastatin also reduced the accumulation of microglia and decreased the expression of TNF-alpha in the demyelinative lesions. These results indicate that microglia play a detrimental role in the pathogenesis of osmotic demyelination by producing proinflammatory cytokines, and further suggest that lovastatin may be useful in repressing the demyelination.
渗透性脱髓鞘是一种由低钠血症快速纠正引起的严重疾病。在人类中,脱髓鞘病变优先发生在脑桥中部,因此被称为中枢性脑桥髓鞘溶解症。尽管在这种脱髓鞘病变中已报道有小胶质细胞的积聚,但其在渗透性脱髓鞘发病机制中的作用仍不清楚。我们研究了在渗透性脱髓鞘大鼠模型的脱髓鞘病变中积聚的小胶质细胞中细胞因子的表达。通过输注去氨加压素和给予流食相结合的方法诱导大鼠出现低钠血症。7天后,通过注射高渗盐水快速纠正血清钠水平。大鼠出现严重的运动功能障碍,并且在中脑和大脑皮质发现了明显的脱髓鞘病变。在脱髓鞘病变区域,观察到大量积聚的小胶质细胞,这些细胞表达促炎细胞因子肿瘤坏死因子-α(TNF-α)、干扰素-γ(IFN-γ)以及诱导型一氧化氮合酶(iNOS)。相比之下,在已知能抑制各种中枢神经系统疾病动物模型中小胶质细胞浸润的洛伐他汀治疗的低钠血症纠正大鼠中,神经功能障碍和脱髓鞘程度得到了显著改善。洛伐他汀还减少了小胶质细胞的积聚,并降低了脱髓鞘病变中TNF-α的表达。这些结果表明,小胶质细胞通过产生促炎细胞因子在渗透性脱髓鞘的发病机制中起有害作用,并且进一步表明洛伐他汀可能有助于抑制脱髓鞘。